<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:ebfa7c08-67e5-4f22-84b2-08652cb3bdc0,g:2e1b7f26-ec90-4bc5-9ee6-6ddc5908cf3e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Cover" xlink:type="simple" xlink:href="jazz-20201231.xsd#Cover"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/Cover" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="jazz-20201231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_55beaded-8892-45e0-b564-64df8955a40d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_29bbb8a5-ead4-4e0b-81e0-df5ba267f01f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_55beaded-8892-45e0-b564-64df8955a40d" xlink:to="loc_us-gaap_LiabilitiesCurrent_29bbb8a5-ead4-4e0b-81e0-df5ba267f01f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_0b43b825-61a4-4e7f-832b-1133e8253d38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_55beaded-8892-45e0-b564-64df8955a40d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_0b43b825-61a4-4e7f-832b-1133e8253d38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_4196ed59-3de7-4931-b2a3-ac5a06b574cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_55beaded-8892-45e0-b564-64df8955a40d" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_4196ed59-3de7-4931-b2a3-ac5a06b574cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_bcd921d8-b448-4782-bc72-283e189aa211" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_55beaded-8892-45e0-b564-64df8955a40d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_bcd921d8-b448-4782-bc72-283e189aa211" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_10391d3a-f5b5-48cf-a1ad-1ae05a53fc1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_55beaded-8892-45e0-b564-64df8955a40d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_10391d3a-f5b5-48cf-a1ad-1ae05a53fc1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_53a92365-3693-4316-920a-9a7d4f66cc2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_55beaded-8892-45e0-b564-64df8955a40d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_53a92365-3693-4316-920a-9a7d4f66cc2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_5a7482c5-9f02-4c8e-ac91-bfd81fdd2e3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_55beaded-8892-45e0-b564-64df8955a40d" xlink:to="loc_us-gaap_CommitmentsAndContingencies_5a7482c5-9f02-4c8e-ac91-bfd81fdd2e3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9c349f99-b035-4d64-bcc3-f01aacdab1fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_55beaded-8892-45e0-b564-64df8955a40d" xlink:to="loc_us-gaap_StockholdersEquity_9c349f99-b035-4d64-bcc3-f01aacdab1fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_163a534a-b748-462a-bd8b-87e466c5be89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_01250bdd-ae1c-4587-909d-33c6a24d9615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_163a534a-b748-462a-bd8b-87e466c5be89" xlink:to="loc_us-gaap_AssetsCurrent_01250bdd-ae1c-4587-909d-33c6a24d9615" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_259be968-b7ea-4564-94f3-361aeab3bbcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_163a534a-b748-462a-bd8b-87e466c5be89" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_259be968-b7ea-4564-94f3-361aeab3bbcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8da56bce-97ea-4e04-b8f1-2aba5d2391bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_163a534a-b748-462a-bd8b-87e466c5be89" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8da56bce-97ea-4e04-b8f1-2aba5d2391bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8ddd1b62-0ab0-4ed4-8019-2523de71ea17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_163a534a-b748-462a-bd8b-87e466c5be89" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8ddd1b62-0ab0-4ed4-8019-2523de71ea17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e15a0018-3246-43ee-aa01-dc2225db385a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_163a534a-b748-462a-bd8b-87e466c5be89" xlink:to="loc_us-gaap_Goodwill_e15a0018-3246-43ee-aa01-dc2225db385a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_75cf7e76-cd93-4137-a157-d77cf0d35781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_163a534a-b748-462a-bd8b-87e466c5be89" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_75cf7e76-cd93-4137-a157-d77cf0d35781" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_94d1e7a2-31fd-455d-8541-3b80f2b690c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_163a534a-b748-462a-bd8b-87e466c5be89" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_94d1e7a2-31fd-455d-8541-3b80f2b690c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ffb28189-a1c9-4605-a258-1ebeadc18139" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_163a534a-b748-462a-bd8b-87e466c5be89" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ffb28189-a1c9-4605-a258-1ebeadc18139" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9492edc9-4246-4433-8239-69cb3b47be5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8ff8f25a-9543-4bdd-a221-f166efe1f8f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9492edc9-4246-4433-8239-69cb3b47be5b" xlink:to="loc_us-gaap_CommonStockValue_8ff8f25a-9543-4bdd-a221-f166efe1f8f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_NonvotingEuroDeferredShares_e7abbb69-dd6d-4312-a2e6-e0a4f71d028a" xlink:href="jazz-20201231.xsd#jazz_NonvotingEuroDeferredShares"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9492edc9-4246-4433-8239-69cb3b47be5b" xlink:to="loc_jazz_NonvotingEuroDeferredShares_e7abbb69-dd6d-4312-a2e6-e0a4f71d028a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CapitalRedemptionReserve_83a7fc4f-9123-4be5-be27-b0fc3122e2d6" xlink:href="jazz-20201231.xsd#jazz_CapitalRedemptionReserve"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9492edc9-4246-4433-8239-69cb3b47be5b" xlink:to="loc_jazz_CapitalRedemptionReserve_83a7fc4f-9123-4be5-be27-b0fc3122e2d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e072c0d8-6718-487a-bbbc-307164989300" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9492edc9-4246-4433-8239-69cb3b47be5b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e072c0d8-6718-487a-bbbc-307164989300" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e4cd3dfb-040f-416f-9cb6-331bf4bf933b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9492edc9-4246-4433-8239-69cb3b47be5b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e4cd3dfb-040f-416f-9cb6-331bf4bf933b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7eb34666-53f2-44b8-b062-49d501df448d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9492edc9-4246-4433-8239-69cb3b47be5b" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7eb34666-53f2-44b8-b062-49d501df448d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_90e08b78-37cb-4f3b-8833-38d346d8cbb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_c6862874-0c92-4535-b5d0-1cc646c275f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_90e08b78-37cb-4f3b-8833-38d346d8cbb5" xlink:to="loc_us-gaap_AccountsPayableCurrent_c6862874-0c92-4535-b5d0-1cc646c275f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_600c533d-3076-46fc-9be2-30d15c97eeb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_90e08b78-37cb-4f3b-8833-38d346d8cbb5" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_600c533d-3076-46fc-9be2-30d15c97eeb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_8b1cd05c-2bd9-4d44-a603-67469e0efe71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_90e08b78-37cb-4f3b-8833-38d346d8cbb5" xlink:to="loc_us-gaap_LongTermDebtCurrent_8b1cd05c-2bd9-4d44-a603-67469e0efe71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_6d6e44e7-2e04-4b1e-8612-a594de22a22f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_90e08b78-37cb-4f3b-8833-38d346d8cbb5" xlink:to="loc_us-gaap_TaxesPayableCurrent_6d6e44e7-2e04-4b1e-8612-a594de22a22f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_174dd603-dc4f-416a-9eab-7a1d5373ce51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_90e08b78-37cb-4f3b-8833-38d346d8cbb5" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_174dd603-dc4f-416a-9eab-7a1d5373ce51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7f1499f7-54a5-4958-8c07-25e766ed1b79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_31245cdb-9267-4d5b-a12e-f94687cf6aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_7f1499f7-54a5-4958-8c07-25e766ed1b79" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_31245cdb-9267-4d5b-a12e-f94687cf6aa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_d3faebb3-4c86-4f2c-a9fa-037acae1113d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_7f1499f7-54a5-4958-8c07-25e766ed1b79" xlink:to="loc_us-gaap_Investments_d3faebb3-4c86-4f2c-a9fa-037acae1113d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_57c0af41-0907-4bac-a5a1-30ffabc05302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_7f1499f7-54a5-4958-8c07-25e766ed1b79" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_57c0af41-0907-4bac-a5a1-30ffabc05302" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f29d02a3-bdd1-4723-8830-acd2d327e261" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_7f1499f7-54a5-4958-8c07-25e766ed1b79" xlink:to="loc_us-gaap_InventoryNet_f29d02a3-bdd1-4723-8830-acd2d327e261" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_58b3cee5-9573-4c6e-ac04-6733a81b4b47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_7f1499f7-54a5-4958-8c07-25e766ed1b79" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_58b3cee5-9573-4c6e-ac04-6733a81b4b47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_d07da4f5-2a18-439a-9890-74656b4600ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_7f1499f7-54a5-4958-8c07-25e766ed1b79" xlink:to="loc_us-gaap_OtherAssetsCurrent_d07da4f5-2a18-439a-9890-74656b4600ba" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="jazz-20201231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="jazz-20201231.xsd#ConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7a6c5825-e59b-4177-83ef-3f5a5466595b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_72470341-f23e-4476-924b-3ae4707e8281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_7a6c5825-e59b-4177-83ef-3f5a5466595b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_72470341-f23e-4476-924b-3ae4707e8281" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_e59278f5-b60e-4140-a166-78790d902911" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_7a6c5825-e59b-4177-83ef-3f5a5466595b" xlink:to="loc_us-gaap_CostsAndExpenses_e59278f5-b60e-4140-a166-78790d902911" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_98b13663-5e26-446b-84d1-8686061db150" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a8e3ffbf-ba9e-4dcb-9573-d36569749b8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_98b13663-5e26-446b-84d1-8686061db150" xlink:to="loc_us-gaap_OperatingIncomeLoss_a8e3ffbf-ba9e-4dcb-9573-d36569749b8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_7a194e97-a972-4fdd-a621-d34a57fcd0d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_98b13663-5e26-446b-84d1-8686061db150" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_7a194e97-a972-4fdd-a621-d34a57fcd0d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_fd1bcc76-4b95-482c-8f78-806253888163" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_98b13663-5e26-446b-84d1-8686061db150" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_fd1bcc76-4b95-482c-8f78-806253888163" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_109bcad2-43d3-42de-bc1b-7bd9cf28a81b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_058cd9e0-d800-4d2a-ab3f-ee79c1f1511c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_109bcad2-43d3-42de-bc1b-7bd9cf28a81b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_058cd9e0-d800-4d2a-ab3f-ee79c1f1511c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fd1f58fc-4938-44ef-8f79-d9efde24375c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_109bcad2-43d3-42de-bc1b-7bd9cf28a81b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_fd1f58fc-4938-44ef-8f79-d9efde24375c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_f3b3c221-a7a5-4e2c-8b14-e242615ae05c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_109bcad2-43d3-42de-bc1b-7bd9cf28a81b" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_f3b3c221-a7a5-4e2c-8b14-e242615ae05c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_ce63d8d6-ef55-4642-aa94-d05702d54752" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_66d43628-f1a3-4c75-83c2-5380e32db230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ce63d8d6-ef55-4642-aa94-d05702d54752" xlink:to="loc_us-gaap_AssetImpairmentCharges_66d43628-f1a3-4c75-83c2-5380e32db230" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_98f11420-4436-41e9-a27e-b5636d50f5ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ce63d8d6-ef55-4642-aa94-d05702d54752" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_98f11420-4436-41e9-a27e-b5636d50f5ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_07c8a173-e654-45b8-a7ec-e9def99cf638" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ce63d8d6-ef55-4642-aa94-d05702d54752" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_07c8a173-e654-45b8-a7ec-e9def99cf638" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment_b864fd6f-3ad3-45ff-ae56-203734ea798f" xlink:href="jazz-20201231.xsd#jazz_CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ce63d8d6-ef55-4642-aa94-d05702d54752" xlink:to="loc_jazz_CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment_b864fd6f-3ad3-45ff-ae56-203734ea798f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_142a3684-7e0a-46cd-8ba2-204eb4f4092e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ce63d8d6-ef55-4642-aa94-d05702d54752" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_142a3684-7e0a-46cd-8ba2-204eb4f4092e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a644229c-07be-46d1-a4a8-33caa377ffad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ce63d8d6-ef55-4642-aa94-d05702d54752" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a644229c-07be-46d1-a4a8-33caa377ffad" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="jazz-20201231.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_11f89957-9b1b-46a1-882f-0b744fbcd2d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3f355c9e-582e-484b-901a-e621f085db67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_11f89957-9b1b-46a1-882f-0b744fbcd2d7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3f355c9e-582e-484b-901a-e621f085db67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5a46ef73-a1c4-4824-9a40-fc29fbcd1b14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_11f89957-9b1b-46a1-882f-0b744fbcd2d7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5a46ef73-a1c4-4824-9a40-fc29fbcd1b14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_af297a28-7b93-4ef9-9b2f-504e3c227cc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_af1f485b-3a59-4333-a0e2-670ac7ada4cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_af297a28-7b93-4ef9-9b2f-504e3c227cc6" xlink:to="loc_us-gaap_NetIncomeLoss_af1f485b-3a59-4333-a0e2-670ac7ada4cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_660bc461-07d2-499f-849b-2b517a6e8d34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_af297a28-7b93-4ef9-9b2f-504e3c227cc6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_660bc461-07d2-499f-849b-2b517a6e8d34" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical" xlink:type="simple" xlink:href="jazz-20201231.xsd#ConsolidatedStatementsofComprehensiveIncomeParenthetical"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="jazz-20201231.xsd#ConsolidatedStatementsofShareholdersEquity"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="jazz-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_8ee13b12-be6f-4448-a354-259ad60188da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_8ee13b12-be6f-4448-a354-259ad60188da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_88b88ade-be6a-4bda-b9b3-1d04af44a227" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_88b88ade-be6a-4bda-b9b3-1d04af44a227" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ee911398-58e8-4d44-8658-f46b13e6955f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ee911398-58e8-4d44-8658-f46b13e6955f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_9dc089b6-02a4-4e07-bf95-85ef75534856" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_us-gaap_Depreciation_9dc089b6-02a4-4e07-bf95-85ef75534856" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_8ce3bd40-22cd-4655-a241-43773d3d3466" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_8ce3bd40-22cd-4655-a241-43773d3d3466" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_IncreaseDecreaseInOperatingLeaseAssets_e51b0c42-a814-4970-9071-25d2d9fbb7d0" xlink:href="jazz-20201231.xsd#jazz_IncreaseDecreaseInOperatingLeaseAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_jazz_IncreaseDecreaseInOperatingLeaseAssets_e51b0c42-a814-4970-9071-25d2d9fbb7d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_0dab98cd-4a4f-4de0-8b86-89fc09f84661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_0dab98cd-4a4f-4de0-8b86-89fc09f84661" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_239ffb16-517a-4608-bedc-3e1761e2d391" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_239ffb16-517a-4608-bedc-3e1761e2d391" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_d3c44de3-e98d-4049-95f0-3e3291305b99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_d3c44de3-e98d-4049-95f0-3e3291305b99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_243f5339-a1bc-4a9e-b348-f069364fd272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_243f5339-a1bc-4a9e-b348-f069364fd272" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_085942e7-8d2a-48b4-a986-dff5d5c89975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_085942e7-8d2a-48b4-a986-dff5d5c89975" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1097f36b-1e90-4ab4-a71c-631c985139a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1097f36b-1e90-4ab4-a71c-631c985139a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_e6b44392-0511-4773-ad04-7c3ac5825149" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_e6b44392-0511-4773-ad04-7c3ac5825149" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9ba06687-d5eb-4958-bdd3-dd7d0df30169" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_us-gaap_ShareBasedCompensation_9ba06687-d5eb-4958-bdd3-dd7d0df30169" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4316b117-1cdb-4bdf-9f83-76a0b5617b9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4316b117-1cdb-4bdf-9f83-76a0b5617b9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ae6d9604-2476-407f-8892-a3640560addd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ae6d9604-2476-407f-8892-a3640560addd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ProvisionForLossesOnAccountsReceivableAndInventory_8fe4f88d-f0b6-4dff-9d5b-584952aca4f8" xlink:href="jazz-20201231.xsd#jazz_ProvisionForLossesOnAccountsReceivableAndInventory"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_jazz_ProvisionForLossesOnAccountsReceivableAndInventory_8fe4f88d-f0b6-4dff-9d5b-584952aca4f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_19bfe3a8-5b37-4cd8-8311-f1220e42bd06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_19bfe3a8-5b37-4cd8-8311-f1220e42bd06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent_c1f30ec0-96d7-4083-bb95-d60494d6a0f7" xlink:href="jazz-20201231.xsd#jazz_IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_jazz_IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent_c1f30ec0-96d7-4083-bb95-d60494d6a0f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5ed6f498-4277-4bfa-a785-e94a4ba8d4f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_us-gaap_NetIncomeLoss_5ed6f498-4277-4bfa-a785-e94a4ba8d4f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_45a0978d-7127-42d2-8689-36bc964e8f9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="21" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_45a0978d-7127-42d2-8689-36bc964e8f9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_5f667687-5e58-4c5e-aa34-4cd465a52313" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="22" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_us-gaap_AssetImpairmentCharges_5f667687-5e58-4c5e-aa34-4cd465a52313" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_GainLossonExtinguishmentandModificationofDebt_a05de061-28b3-4327-b3f4-61af082bf7f8" xlink:href="jazz-20201231.xsd#jazz_GainLossonExtinguishmentandModificationofDebt"/>
    <link:calculationArc order="23" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83132fb3-580e-4d1b-8bdd-aa01317c8dd6" xlink:to="loc_jazz_GainLossonExtinguishmentandModificationofDebt_a05de061-28b3-4327-b3f4-61af082bf7f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c956699-d637-4d81-852e-921fef3759a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4311a0cf-7686-4a9a-9c59-4aba343d7d2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c956699-d637-4d81-852e-921fef3759a2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4311a0cf-7686-4a9a-9c59-4aba343d7d2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_86f6e35f-aed9-40ba-8f1b-f94af613ba62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c956699-d637-4d81-852e-921fef3759a2" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_86f6e35f-aed9-40ba-8f1b-f94af613ba62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_2a11d8a5-3c91-4c85-b3c9-136b694a7045" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c956699-d637-4d81-852e-921fef3759a2" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_2a11d8a5-3c91-4c85-b3c9-136b694a7045" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_d1d1e8cf-39c1-4277-9cf5-1e3b76b08e5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c956699-d637-4d81-852e-921fef3759a2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_d1d1e8cf-39c1-4277-9cf5-1e3b76b08e5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_d6c326d3-75d6-4277-b863-a774e64a6046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c956699-d637-4d81-852e-921fef3759a2" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_d6c326d3-75d6-4277-b863-a774e64a6046" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7c4982bd-362b-4a41-a9d2-e6be6e90508e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c956699-d637-4d81-852e-921fef3759a2" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7c4982bd-362b-4a41-a9d2-e6be6e90508e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtRestructuringCosts_1d196f30-f8f7-4d7b-aabe-6e9e14be4fed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtRestructuringCosts"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c956699-d637-4d81-852e-921fef3759a2" xlink:to="loc_us-gaap_PaymentsOfDebtRestructuringCosts_1d196f30-f8f7-4d7b-aabe-6e9e14be4fed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_9530e9f3-4224-46ee-ab8d-0a31e3491522" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c956699-d637-4d81-852e-921fef3759a2" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_9530e9f3-4224-46ee-ab8d-0a31e3491522" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_bcb7bcd3-27ff-4f80-b6cd-d217e8c7899d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c956699-d637-4d81-852e-921fef3759a2" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_bcb7bcd3-27ff-4f80-b6cd-d217e8c7899d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_PaymentsForProceedsFromTenantAllowanceFinancingActivities_900c5889-a584-4db2-829b-c038a7cd7418" xlink:href="jazz-20201231.xsd#jazz_PaymentsForProceedsFromTenantAllowanceFinancingActivities"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c956699-d637-4d81-852e-921fef3759a2" xlink:to="loc_jazz_PaymentsForProceedsFromTenantAllowanceFinancingActivities_900c5889-a584-4db2-829b-c038a7cd7418" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2d98fcb3-2719-4462-afe3-16472fb7bd44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3ad5274-8d24-4f2f-8c1a-aa200c24949a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2d98fcb3-2719-4462-afe3-16472fb7bd44" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3ad5274-8d24-4f2f-8c1a-aa200c24949a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ea09cabc-5d0e-4fa1-9248-b0e5930d9a2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2d98fcb3-2719-4462-afe3-16472fb7bd44" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ea09cabc-5d0e-4fa1-9248-b0e5930d9a2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4739ed9d-5283-4bfd-8c2d-819b38b6bb79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2d98fcb3-2719-4462-afe3-16472fb7bd44" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4739ed9d-5283-4bfd-8c2d-819b38b6bb79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_865cba72-8fb8-457f-91bc-59ea0ce7f057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2d98fcb3-2719-4462-afe3-16472fb7bd44" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_865cba72-8fb8-457f-91bc-59ea0ce7f057" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_49f198d4-0546-4a80-8a93-acb9940222b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_fbf1936b-878a-4229-8cb1-5f0a51fdc878" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_49f198d4-0546-4a80-8a93-acb9940222b5" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_fbf1936b-878a-4229-8cb1-5f0a51fdc878" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_511ec9ad-3bf3-46d2-b43f-76d93552a25b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_49f198d4-0546-4a80-8a93-acb9940222b5" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_511ec9ad-3bf3-46d2-b43f-76d93552a25b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_PaymentToAcquireAssetsNetOfCashAcquired_ceeabc82-996d-45ef-b7ad-36a729730956" xlink:href="jazz-20201231.xsd#jazz_PaymentToAcquireAssetsNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_49f198d4-0546-4a80-8a93-acb9940222b5" xlink:to="loc_jazz_PaymentToAcquireAssetsNetOfCashAcquired_ceeabc82-996d-45ef-b7ad-36a729730956" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_fc7c6fde-2ad4-4987-a1de-4405ef4c638e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_49f198d4-0546-4a80-8a93-acb9940222b5" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_fc7c6fde-2ad4-4987-a1de-4405ef4c638e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination_a8cb291b-40f0-46a3-ba63-07883af7be96" xlink:href="jazz-20201231.xsd#jazz_PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_49f198d4-0546-4a80-8a93-acb9940222b5" xlink:to="loc_jazz_PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination_a8cb291b-40f0-46a3-ba63-07883af7be96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_4522867c-50b0-4ea3-84f9-c30714d31889" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_49f198d4-0546-4a80-8a93-acb9940222b5" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_4522867c-50b0-4ea3-84f9-c30714d31889" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_0a1a66b8-b601-466f-bdf0-dda6d610cae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_49f198d4-0546-4a80-8a93-acb9940222b5" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_0a1a66b8-b601-466f-bdf0-dda6d610cae1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/OrganizationandDescriptionofBusiness" xlink:type="simple" xlink:href="jazz-20201231.xsd#OrganizationandDescriptionofBusiness"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/OrganizationandDescriptionofBusiness" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="jazz-20201231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="jazz-20201231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="jazz-20201231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentEstimatedUsefulLivesDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentEstimatedUsefulLivesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentEstimatedUsefulLivesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/AssetAcquisitionCollaborationsandDisposition" xlink:type="simple" xlink:href="jazz-20201231.xsd#AssetAcquisitionCollaborationsandDisposition"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/AssetAcquisitionCollaborationsandDisposition" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/AssetAcquisitionCollaborationsandDispositionTables" xlink:type="simple" xlink:href="jazz-20201231.xsd#AssetAcquisitionCollaborationsandDispositionTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/AssetAcquisitionCollaborationsandDispositionTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/AssetAcquisitionCollaborationsandDispositionAssetAcquisitionsandLicenseAgreementsNarrativeDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#AssetAcquisitionCollaborationsandDispositionAssetAcquisitionsandLicenseAgreementsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/AssetAcquisitionCollaborationsandDispositionAssetAcquisitionsandLicenseAgreementsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/AssetAcquisitionCollaborationsandDispositionScheduleofAssetAcquisitionDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#AssetAcquisitionCollaborationsandDispositionScheduleofAssetAcquisitionDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/AssetAcquisitionCollaborationsandDispositionScheduleofAssetAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_8e85adb6-ca86-4145-9be3-850e0a32b901" xlink:href="jazz-20201231.xsd#jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_97a3cbcb-46b1-4006-bf14-33a2bbbf0a58" xlink:href="jazz-20201231.xsd#jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_8e85adb6-ca86-4145-9be3-850e0a32b901" xlink:to="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_97a3cbcb-46b1-4006-bf14-33a2bbbf0a58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_9bcab868-1407-4c57-b46b-f344b1062dc5" xlink:href="jazz-20201231.xsd#jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_8e85adb6-ca86-4145-9be3-850e0a32b901" xlink:to="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_9bcab868-1407-4c57-b46b-f344b1062dc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_8cba53bc-4df4-4982-8030-a768ded4b87f" xlink:href="jazz-20201231.xsd#jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_8e85adb6-ca86-4145-9be3-850e0a32b901" xlink:to="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_8cba53bc-4df4-4982-8030-a768ded4b87f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilitiesNet_ed5d3b0c-d3d8-4e66-b8b6-ca302b8875ee" xlink:href="jazz-20201231.xsd#jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_8e85adb6-ca86-4145-9be3-850e0a32b901" xlink:to="loc_jazz_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilitiesNet_ed5d3b0c-d3d8-4e66-b8b6-ca302b8875ee" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/AssetAcquisitionCollaborationsandDispositionCollaborationandLicenseAgreementNarrativeDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#AssetAcquisitionCollaborationsandDispositionCollaborationandLicenseAgreementNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/AssetAcquisitionCollaborationsandDispositionCollaborationandLicenseAgreementNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/AssetAcquisitionCollaborationsandDispositionCollaborationandOptionAgreementNarrativeDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#AssetAcquisitionCollaborationsandDispositionCollaborationandOptionAgreementNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/AssetAcquisitionCollaborationsandDispositionCollaborationandOptionAgreementNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/AssetAcquisitionCollaborationsandDispositionDispositionNarrativeDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#AssetAcquisitionCollaborationsandDispositionDispositionNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/AssetAcquisitionCollaborationsandDispositionDispositionNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CashandAvailableforSaleSecurities" xlink:type="simple" xlink:href="jazz-20201231.xsd#CashandAvailableforSaleSecurities"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CashandAvailableforSaleSecurities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesTables" xlink:type="simple" xlink:href="jazz-20201231.xsd#CashandAvailableforSaleSecuritiesTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesSummaryofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#CashandAvailableforSaleSecuritiesSummaryofCashandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesSummaryofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_c6c1f611-f09e-45fb-be14-e60c067a1799" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_780ee48f-c18e-41cf-8d15-1677b8fbdc69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_c6c1f611-f09e-45fb-be14-e60c067a1799" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_780ee48f-c18e-41cf-8d15-1677b8fbdc69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b4cdc5c0-515f-4e19-b4b9-458f7057cfe5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_c6c1f611-f09e-45fb-be14-e60c067a1799" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b4cdc5c0-515f-4e19-b4b9-458f7057cfe5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_de4d85d3-59d0-4acc-bd82-82726ca61020" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_c6c1f611-f09e-45fb-be14-e60c067a1799" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_de4d85d3-59d0-4acc-bd82-82726ca61020" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/FairValueMeasurement" xlink:type="simple" xlink:href="jazz-20201231.xsd#FairValueMeasurement"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/FairValueMeasurement" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/FairValueMeasurementTables" xlink:type="simple" xlink:href="jazz-20201231.xsd#FairValueMeasurementTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/FairValueMeasurementTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_5b1064ef-ad94-4f15-be54-61e08d3ada2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_9f6f0b5d-69a6-4655-8bc3-030a36bb5bc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_5b1064ef-ad94-4f15-be54-61e08d3ada2f" xlink:to="loc_us-gaap_DerivativeLiabilities_9f6f0b5d-69a6-4655-8bc3-030a36bb5bc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_b155dde3-174c-48b3-800e-512233d10775" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7b404b51-9679-4496-aed9-96f1db3cd032" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_b155dde3-174c-48b3-800e-512233d10775" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7b404b51-9679-4496-aed9-96f1db3cd032" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_0ed83619-c022-4eee-ab38-0ae09ed80ea6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_b155dde3-174c-48b3-800e-512233d10775" xlink:to="loc_us-gaap_DerivativeAssets_0ed83619-c022-4eee-ab38-0ae09ed80ea6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/FairValueMeasurementNarrativeDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#FairValueMeasurementNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/FairValueMeasurementNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivities" xlink:type="simple" xlink:href="jazz-20201231.xsd#DerivativeInstrumentsandHedgingActivities"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="simple" xlink:href="jazz-20201231.xsd#DerivativeInstrumentsandHedgingActivitiesTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesGainsandLossesonDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#DerivativeInstrumentsandHedgingActivitiesGainsandLossesonDerivativeInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesGainsandLossesonDerivativeInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesForeignExchangeGainLossDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#DerivativeInstrumentsandHedgingActivitiesForeignExchangeGainLossDerivativeInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesForeignExchangeGainLossDerivativeInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesFairValueofOutstandingDerivativesDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#DerivativeInstrumentsandHedgingActivitiesFairValueofOutstandingDerivativesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesFairValueofOutstandingDerivativesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesOffsettingAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#DerivativeInstrumentsandHedgingActivitiesOffsettingAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesOffsettingAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_5fe87641-d121-4af5-9a4c-53a45d089d48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_5b59ec3d-af35-4106-a53c-1f7625cb464e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilities_5fe87641-d121-4af5-9a4c-53a45d089d48" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_5b59ec3d-af35-4106-a53c-1f7625cb464e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_08cd75c0-7b7b-4312-9167-0950331095da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilities_5fe87641-d121-4af5-9a4c-53a45d089d48" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_08cd75c0-7b7b-4312-9167-0950331095da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_78ac33ad-8468-439b-a60b-b1839f261561" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_b32c048e-55d1-4f59-8c58-90876348bc55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssets_78ac33ad-8468-439b-a60b-b1839f261561" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_b32c048e-55d1-4f59-8c58-90876348bc55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability_5118d8b6-0ebf-4a7e-9f12-348e06ee9b01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssets_78ac33ad-8468-439b-a60b-b1839f261561" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossLiability_5118d8b6-0ebf-4a7e-9f12-348e06ee9b01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_d9b5e80b-b7ae-4147-b213-d0500d851e3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_a6b6e3d6-596b-4254-999d-d057f8735658" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_d9b5e80b-b7ae-4147-b213-d0500d851e3e" xlink:to="loc_us-gaap_DerivativeLiabilities_a6b6e3d6-596b-4254-999d-d057f8735658" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimSecurities_2fd3632f-bcab-4004-8197-3adda9bba262" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCollateralRightToReclaimSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_d9b5e80b-b7ae-4147-b213-d0500d851e3e" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimSecurities_2fd3632f-bcab-4004-8197-3adda9bba262" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_cd3506c7-dd51-411a-b0eb-ae73366debcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_d9b5e80b-b7ae-4147-b213-d0500d851e3e" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_cd3506c7-dd51-411a-b0eb-ae73366debcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_44ecf8e7-2dac-4d76-8472-c201bdb3576a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_654113f0-8eb1-4971-8522-043080c6e186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_44ecf8e7-2dac-4d76-8472-c201bdb3576a" xlink:to="loc_us-gaap_DerivativeAssets_654113f0-8eb1-4971-8522-043080c6e186" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnSecurities_2068006c-ca44-4d39-bbd5-a0a4ad039fc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCollateralObligationToReturnSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_44ecf8e7-2dac-4d76-8472-c201bdb3576a" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnSecurities_2068006c-ca44-4d39-bbd5-a0a4ad039fc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_aba20bf5-a084-4bc1-b23f-cb2c1148d6e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_44ecf8e7-2dac-4d76-8472-c201bdb3576a" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_aba20bf5-a084-4bc1-b23f-cb2c1148d6e2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Inventories" xlink:type="simple" xlink:href="jazz-20201231.xsd#Inventories"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/Inventories" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/InventoriesTables" xlink:type="simple" xlink:href="jazz-20201231.xsd#InventoriesTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/InventoriesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/InventoriesScheduleofInventoriesDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#InventoriesScheduleofInventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/InventoriesScheduleofInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4b19bcac-8758-403d-a15a-7371cbadcf49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_0fa4dd96-f26c-4045-b0a4-a9d910f999cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_4b19bcac-8758-403d-a15a-7371cbadcf49" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_0fa4dd96-f26c-4045-b0a4-a9d910f999cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_1526e3d3-79ed-4843-92fe-7c684335f38c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_4b19bcac-8758-403d-a15a-7371cbadcf49" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_1526e3d3-79ed-4843-92fe-7c684335f38c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_010dce13-7dcc-468d-9948-8975c191636d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_4b19bcac-8758-403d-a15a-7371cbadcf49" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_010dce13-7dcc-468d-9948-8975c191636d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/PropertyPlantandEquipment" xlink:type="simple" xlink:href="jazz-20201231.xsd#PropertyPlantandEquipment"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/PropertyPlantandEquipment" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/PropertyPlantandEquipmentTables" xlink:type="simple" xlink:href="jazz-20201231.xsd#PropertyPlantandEquipmentTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/PropertyPlantandEquipmentTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/PropertyPlantandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#PropertyPlantandEquipmentScheduleofPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/PropertyPlantandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_db3d03fb-016e-4aae-916f-582d60b05cbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_aefbeeca-b7cb-4053-a771-237e5ee93286" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_db3d03fb-016e-4aae-916f-582d60b05cbd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_aefbeeca-b7cb-4053-a771-237e5ee93286" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c97ce210-7357-4676-a077-b5283c502c47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_db3d03fb-016e-4aae-916f-582d60b05cbd" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c97ce210-7357-4676-a077-b5283c502c47" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="jazz-20201231.xsd#GoodwillandIntangibleAssets"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssets" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="jazz-20201231.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsScheduleofGrossCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#GoodwillandIntangibleAssetsScheduleofGrossCarryingAmountofGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsScheduleofGrossCarryingAmountofGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsScheduleofGrossCarryingAmountsandNetBookValuesofIntangibleAssetsDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#GoodwillandIntangibleAssetsScheduleofGrossCarryingAmountsandNetBookValuesofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsScheduleofGrossCarryingAmountsandNetBookValuesofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2428878e-09e3-4a08-aada-d10e83b0198a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d95633ab-b53f-4ec0-8035-f4cc229ee9b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2428878e-09e3-4a08-aada-d10e83b0198a" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d95633ab-b53f-4ec0-8035-f4cc229ee9b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7b828941-ac0c-405c-8fcb-b9b6e93ae763" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2428878e-09e3-4a08-aada-d10e83b0198a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7b828941-ac0c-405c-8fcb-b9b6e93ae763" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7c578420-0c2c-4644-b1ce-5640a9134a01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3d45a1e0-1d2e-4815-8d3e-972ac1c0a764" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7c578420-0c2c-4644-b1ce-5640a9134a01" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3d45a1e0-1d2e-4815-8d3e-972ac1c0a764" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_91049f12-5728-451b-8024-46e780f197a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7c578420-0c2c-4644-b1ce-5640a9134a01" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_91049f12-5728-451b-8024-46e780f197a0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsScheduleofEstimatedFutureAmortizationCostsDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#GoodwillandIntangibleAssetsScheduleofEstimatedFutureAmortizationCostsDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsScheduleofEstimatedFutureAmortizationCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cb62494e-43b8-46d8-bf58-c0d50ee512ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4daac3f0-f05d-4a08-8cbb-a41da6f38a9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cb62494e-43b8-46d8-bf58-c0d50ee512ac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4daac3f0-f05d-4a08-8cbb-a41da6f38a9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ab6bec9f-a7a5-4bed-b98b-96e54df3ba11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cb62494e-43b8-46d8-bf58-c0d50ee512ac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ab6bec9f-a7a5-4bed-b98b-96e54df3ba11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d9cfa4bd-87d3-4239-bc53-93ea6d7e631f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cb62494e-43b8-46d8-bf58-c0d50ee512ac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d9cfa4bd-87d3-4239-bc53-93ea6d7e631f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_a9ed0ae0-26cf-46ca-9f5d-7e2b50e00ee9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cb62494e-43b8-46d8-bf58-c0d50ee512ac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_a9ed0ae0-26cf-46ca-9f5d-7e2b50e00ee9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_22e55123-ab90-4d3d-a57d-5dc3e16725c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cb62494e-43b8-46d8-bf58-c0d50ee512ac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_22e55123-ab90-4d3d-a57d-5dc3e16725c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_3d799e4f-d8e0-49ff-a1f2-72a2ef4499f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cb62494e-43b8-46d8-bf58-c0d50ee512ac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_3d799e4f-d8e0-49ff-a1f2-72a2ef4499f9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/AccruedLiabilities" xlink:type="simple" xlink:href="jazz-20201231.xsd#AccruedLiabilities"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/AccruedLiabilities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/AccruedLiabilitiesTables" xlink:type="simple" xlink:href="jazz-20201231.xsd#AccruedLiabilitiesTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/AccruedLiabilitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/AccruedLiabilitiesScheduleofAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#AccruedLiabilitiesScheduleofAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/AccruedLiabilitiesScheduleofAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_6c6df7c8-f3af-4c47-8fb0-7edb538827a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedRebatesAndOtherSalesDeductions_d9dea30f-7bcf-4040-afaf-f37072f8a793" xlink:href="jazz-20201231.xsd#jazz_AccruedRebatesAndOtherSalesDeductions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_6c6df7c8-f3af-4c47-8fb0-7edb538827a4" xlink:to="loc_jazz_AccruedRebatesAndOtherSalesDeductions_d9dea30f-7bcf-4040-afaf-f37072f8a793" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SalesReturnReserve_2d4abfff-7e6f-4bdd-b39c-77c4a9be7a60" xlink:href="jazz-20201231.xsd#jazz_SalesReturnReserve"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_6c6df7c8-f3af-4c47-8fb0-7edb538827a4" xlink:to="loc_jazz_SalesReturnReserve_2d4abfff-7e6f-4bdd-b39c-77c4a9be7a60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedClinicalTrialLiability_b9359f43-5f96-4ec4-991d-4c8ad1e6b5d0" xlink:href="jazz-20201231.xsd#jazz_AccruedClinicalTrialLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_6c6df7c8-f3af-4c47-8fb0-7edb538827a4" xlink:to="loc_jazz_AccruedClinicalTrialLiability_b9359f43-5f96-4ec4-991d-4c8ad1e6b5d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d42c141b-2f41-4a2d-9216-478022230cdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_6c6df7c8-f3af-4c47-8fb0-7edb538827a4" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d42c141b-2f41-4a2d-9216-478022230cdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedConstructionInProgress_2dfd2555-cc83-4c53-8ab5-c8dfccb91549" xlink:href="jazz-20201231.xsd#jazz_AccruedConstructionInProgress"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_6c6df7c8-f3af-4c47-8fb0-7edb538827a4" xlink:to="loc_jazz_AccruedConstructionInProgress_2dfd2555-cc83-4c53-8ab5-c8dfccb91549" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedCollaborationCostsCurrent_b684f3f8-3ac7-4231-8bca-5bf955f5aee2" xlink:href="jazz-20201231.xsd#jazz_AccruedCollaborationCostsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_6c6df7c8-f3af-4c47-8fb0-7edb538827a4" xlink:to="loc_jazz_AccruedCollaborationCostsCurrent_b684f3f8-3ac7-4231-8bca-5bf955f5aee2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_4ba5d3e5-c45b-4fde-9f2e-f2918a2c2d5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_6c6df7c8-f3af-4c47-8fb0-7edb538827a4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_4ba5d3e5-c45b-4fde-9f2e-f2918a2c2d5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_31dbcd40-7c72-4103-bd7e-6b894bbdac14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_6c6df7c8-f3af-4c47-8fb0-7edb538827a4" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_31dbcd40-7c72-4103-bd7e-6b894bbdac14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_90e335e0-3218-4de7-a8d8-19d7c7e605c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_6c6df7c8-f3af-4c47-8fb0-7edb538827a4" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_90e335e0-3218-4de7-a8d8-19d7c7e605c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_c8f312f9-be93-4a31-9b3b-3ac83169dfa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_6c6df7c8-f3af-4c47-8fb0-7edb538827a4" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_c8f312f9-be93-4a31-9b3b-3ac83169dfa1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedInventoryRelatedLiabilities_8268b145-a132-4fb8-920f-a94ee6c8d2b0" xlink:href="jazz-20201231.xsd#jazz_AccruedInventoryRelatedLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_6c6df7c8-f3af-4c47-8fb0-7edb538827a4" xlink:to="loc_jazz_AccruedInventoryRelatedLiabilities_8268b145-a132-4fb8-920f-a94ee6c8d2b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedInterest_8fb3bcaa-5645-42a0-8f61-1ee11153cbf7" xlink:href="jazz-20201231.xsd#jazz_AccruedInterest"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_6c6df7c8-f3af-4c47-8fb0-7edb538827a4" xlink:to="loc_jazz_AccruedInterest_8fb3bcaa-5645-42a0-8f61-1ee11153cbf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_08c972d5-49ca-40cb-a6bb-663266d38d2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_6c6df7c8-f3af-4c47-8fb0-7edb538827a4" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_08c972d5-49ca-40cb-a6bb-663266d38d2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_061e24ae-bbd0-4464-9e6d-760572e8cd29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_6c6df7c8-f3af-4c47-8fb0-7edb538827a4" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_061e24ae-bbd0-4464-9e6d-760572e8cd29" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Debt" xlink:type="simple" xlink:href="jazz-20201231.xsd#Debt"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/Debt" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtTables" xlink:type="simple" xlink:href="jazz-20201231.xsd#DebtTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DebtTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtScheduleofDebtDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#DebtScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_817816e2-8d88-4115-98c5-662e7b468b66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_100c4887-6026-480e-99d8-dd4cce789e73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_817816e2-8d88-4115-98c5-662e7b468b66" xlink:to="loc_us-gaap_LongTermDebtCurrent_100c4887-6026-480e-99d8-dd4cce789e73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_b66d94d2-ad6c-43d6-9bf0-c14db77815ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_817816e2-8d88-4115-98c5-662e7b468b66" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_b66d94d2-ad6c-43d6-9bf0-c14db77815ab" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtScheduleofDebtDetails_1" xlink:type="simple" xlink:href="jazz-20201231.xsd#DebtScheduleofDebtDetails_1"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DebtScheduleofDebtDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_1e9848eb-8e88-42ae-994f-4e02dba5e06d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a0c927a0-8a2c-4b24-a79d-e111f2fb4204" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_1e9848eb-8e88-42ae-994f-4e02dba5e06d" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a0c927a0-8a2c-4b24-a79d-e111f2fb4204" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_99019dc2-d22e-4fbd-86dd-908d43fc1610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_1e9848eb-8e88-42ae-994f-4e02dba5e06d" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_99019dc2-d22e-4fbd-86dd-908d43fc1610" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtCreditAgreementNarrativeDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#DebtCreditAgreementNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DebtCreditAgreementNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtExchangeableSeniorNotesDue2026NarrativeDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#DebtExchangeableSeniorNotesDue2026NarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DebtExchangeableSeniorNotesDue2026NarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtExchangeableSeniorNotesDue2024NarrativeDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#DebtExchangeableSeniorNotesDue2024NarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DebtExchangeableSeniorNotesDue2024NarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtExchangeableSeniorNotesDue2021NarrativeDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#DebtExchangeableSeniorNotesDue2021NarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DebtExchangeableSeniorNotesDue2021NarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtScheduleofDebtMaturitiesDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#DebtScheduleofDebtMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DebtScheduleofDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_162de955-7037-4de8-8f6f-63592488d612" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_LongTermDebtMaturityAfterYearFour_1e834fa1-0ffb-4ebc-8a8b-81d8bf5b615d" xlink:href="jazz-20201231.xsd#jazz_LongTermDebtMaturityAfterYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_162de955-7037-4de8-8f6f-63592488d612" xlink:to="loc_jazz_LongTermDebtMaturityAfterYearFour_1e834fa1-0ffb-4ebc-8a8b-81d8bf5b615d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_fc8e4bf2-b0c7-4d78-bf74-f1dcec2832ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_162de955-7037-4de8-8f6f-63592488d612" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_fc8e4bf2-b0c7-4d78-bf74-f1dcec2832ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_d4d7bca0-5a6c-4f94-a091-80cdd38e8c07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_162de955-7037-4de8-8f6f-63592488d612" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_d4d7bca0-5a6c-4f94-a091-80cdd38e8c07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_142ba0b0-daae-4210-927a-1d1171311b0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_162de955-7037-4de8-8f6f-63592488d612" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_142ba0b0-daae-4210-927a-1d1171311b0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_16c26362-d18a-4df5-8843-806c4878f894" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_162de955-7037-4de8-8f6f-63592488d612" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_16c26362-d18a-4df5-8843-806c4878f894" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Leases" xlink:type="simple" xlink:href="jazz-20201231.xsd#Leases"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesTables" xlink:type="simple" xlink:href="jazz-20201231.xsd#LeasesTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LeasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#LeasesLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_9a9f5339-5458-489d-88f8-8bcd65ea3484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_f36ef5d4-62cf-42a8-b574-91ed450a0eb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_9a9f5339-5458-489d-88f8-8bcd65ea3484" xlink:to="loc_us-gaap_OperatingLeaseCost_f36ef5d4-62cf-42a8-b574-91ed450a0eb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_6fea4ca0-c6e0-47bd-a7d4-65d7589eebbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_9a9f5339-5458-489d-88f8-8bcd65ea3484" xlink:to="loc_us-gaap_ShortTermLeaseCost_6fea4ca0-c6e0-47bd-a7d4-65d7589eebbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_93158ba5-ff75-4b1f-8b6b-15861a89c71f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_9a9f5339-5458-489d-88f8-8bcd65ea3484" xlink:to="loc_us-gaap_VariableLeaseCost_93158ba5-ff75-4b1f-8b6b-15861a89c71f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_6dc64a7e-c4a8-4bc3-a17b-67dde53427e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_9a9f5339-5458-489d-88f8-8bcd65ea3484" xlink:to="loc_us-gaap_SubleaseIncome_6dc64a7e-c4a8-4bc3-a17b-67dde53427e2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c9d6a256-8b9a-4d9f-9af2-eef440da2051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6b0cc9c5-c4cd-465a-8ace-c02c9f93bc3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_c9d6a256-8b9a-4d9f-9af2-eef440da2051" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6b0cc9c5-c4cd-465a-8ace-c02c9f93bc3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a6743a7d-073c-4815-8bd7-5c2bd6b69c51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_c9d6a256-8b9a-4d9f-9af2-eef440da2051" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a6743a7d-073c-4815-8bd7-5c2bd6b69c51" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesWeightedAverageTermsandDiscountRatesDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#LeasesWeightedAverageTermsandDiscountRatesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LeasesWeightedAverageTermsandDiscountRatesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#LeasesSupplementalCashFlowInformationDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ca703251-32ad-439e-b55e-0f80191e2d4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_6b860135-e485-44f0-8665-94ec70224f64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ca703251-32ad-439e-b55e-0f80191e2d4a" xlink:to="loc_us-gaap_OperatingLeaseLiability_6b860135-e485-44f0-8665-94ec70224f64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a0380c7b-3fe5-40b0-987c-f821836bc53e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ca703251-32ad-439e-b55e-0f80191e2d4a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a0380c7b-3fe5-40b0-987c-f821836bc53e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="jazz-20201231.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c7643d65-c3e2-481b-a296-eb2155c721f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5b30cc6b-d8a3-48f6-9edd-5c14412b8661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c7643d65-c3e2-481b-a296-eb2155c721f6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5b30cc6b-d8a3-48f6-9edd-5c14412b8661" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_432fe75a-ad40-4ae6-99a3-8f673acd9251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c7643d65-c3e2-481b-a296-eb2155c721f6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_432fe75a-ad40-4ae6-99a3-8f673acd9251" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1d86bda2-e1b6-43c8-a5c5-db2b4f255c75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c7643d65-c3e2-481b-a296-eb2155c721f6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1d86bda2-e1b6-43c8-a5c5-db2b4f255c75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b5274fe4-9650-4d16-bf68-5f5643cea2c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c7643d65-c3e2-481b-a296-eb2155c721f6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b5274fe4-9650-4d16-bf68-5f5643cea2c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_958db1b4-6871-4a61-9878-6acbed89f5d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c7643d65-c3e2-481b-a296-eb2155c721f6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_958db1b4-6871-4a61-9878-6acbed89f5d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1271fd02-4ccc-42b1-b1e0-49e405a54ab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c7643d65-c3e2-481b-a296-eb2155c721f6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1271fd02-4ccc-42b1-b1e0-49e405a54ab4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="jazz-20201231.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CommitmentsandContingenciesLeasesandOtherCommitmentsDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#CommitmentsandContingenciesLeasesandOtherCommitmentsDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CommitmentsandContingenciesLeasesandOtherCommitmentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="jazz-20201231.xsd#ShareholdersEquity"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="jazz-20201231.xsd#ShareholdersEquityTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareholdersEquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#ShareholdersEquityNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareholdersEquityScheduleofAuthorizedButUnissuedOrdinarySharesDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#ShareholdersEquityScheduleofAuthorizedButUnissuedOrdinarySharesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareholdersEquityScheduleofAuthorizedButUnissuedOrdinarySharesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ComprehensiveIncomeLoss" xlink:type="simple" xlink:href="jazz-20201231.xsd#ComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ComprehensiveIncomeLoss" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ComprehensiveIncomeLossTables" xlink:type="simple" xlink:href="jazz-20201231.xsd#ComprehensiveIncomeLossTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ComprehensiveIncomeLossTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ComprehensiveIncomeLossComponentsofAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#ComprehensiveIncomeLossComponentsofAccumulatedOtherComprehensiveLossDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ComprehensiveIncomeLossComponentsofAccumulatedOtherComprehensiveLossDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShare" xlink:type="simple" xlink:href="jazz-20201231.xsd#NetIncomeperOrdinaryShare"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShareTables" xlink:type="simple" xlink:href="jazz-20201231.xsd#NetIncomeperOrdinaryShareTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShareBasicandDilutedNetIncomeLossperCommonShareDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#NetIncomeperOrdinaryShareBasicandDilutedNetIncomeLossperCommonShareDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShareBasicandDilutedNetIncomeLossperCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6046fa92-01bc-42b5-8f36-c36d0ac47340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e720a082-c0d9-4dd3-8eb9-cd8d70845ab1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6046fa92-01bc-42b5-8f36-c36d0ac47340" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e720a082-c0d9-4dd3-8eb9-cd8d70845ab1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_043ad93e-5480-4e88-b548-df226199018c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6046fa92-01bc-42b5-8f36-c36d0ac47340" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_043ad93e-5480-4e88-b548-df226199018c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShareWeightedAverageOrdinarySharesExcludedfromComputationofDilutedNetIncomeperShareDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#NetIncomeperOrdinaryShareWeightedAverageOrdinarySharesExcludedfromComputationofDilutedNetIncomeperShareDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShareWeightedAverageOrdinarySharesExcludedfromComputationofDilutedNetIncomeperShareDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/SegmentandOtherInformation" xlink:type="simple" xlink:href="jazz-20201231.xsd#SegmentandOtherInformation"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/SegmentandOtherInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/SegmentandOtherInformationTables" xlink:type="simple" xlink:href="jazz-20201231.xsd#SegmentandOtherInformationTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/SegmentandOtherInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/SegmentandOtherInformationNarrativeDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#SegmentandOtherInformationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/SegmentandOtherInformationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/SegmentandOtherInformationTotalLongLivedAssetsbyLocationDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#SegmentandOtherInformationTotalLongLivedAssetsbyLocationDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/SegmentandOtherInformationTotalLongLivedAssetsbyLocationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Revenues" xlink:type="simple" xlink:href="jazz-20201231.xsd#Revenues"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/Revenues" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesTables" xlink:type="simple" xlink:href="jazz-20201231.xsd#RevenuesTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/RevenuesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesSummaryofDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#RevenuesSummaryofDisaggregationofRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/RevenuesSummaryofDisaggregationofRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesSummaryofthePercentageofTotalRevenuesfromCustomersDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#RevenuesSummaryofthePercentageofTotalRevenuesfromCustomersDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/RevenuesSummaryofthePercentageofTotalRevenuesfromCustomersDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesNarrativeDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#RevenuesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/RevenuesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesSummaryofContractLiabilitiesDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#RevenuesSummaryofContractLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/RevenuesSummaryofContractLiabilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="jazz-20201231.xsd#ShareBasedCompensation"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="jazz-20201231.xsd#ShareBasedCompensationTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedinBlackScholesOptionPricingModelandResultingWeightedAverageGrantDateFairValueofShareOptionsGrantedDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedinBlackScholesOptionPricingModelandResultingWeightedAverageGrantDateFairValueofShareOptionsGrantedDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedinBlackScholesOptionPricingModelandResultingWeightedAverageGrantDateFairValueofShareOptionsGrantedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationScheduleofStockBasedCompensationExpenseRelatedtoStockOptionsRSUsOrdinarySharesCreditedtoDirectorsPhantomShareAccountsandGrantsunderESPPDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#ShareBasedCompensationScheduleofStockBasedCompensationExpenseRelatedtoStockOptionsRSUsOrdinarySharesCreditedtoDirectorsPhantomShareAccountsandGrantsunderESPPDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationScheduleofStockBasedCompensationExpenseRelatedtoStockOptionsRSUsOrdinarySharesCreditedtoDirectorsPhantomShareAccountsandGrantsunderESPPDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_103fd36f-8744-4164-a5c6-e08a4c9c16f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2e364433-4723-4bcd-b8a3-c78a38fb60ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_103fd36f-8744-4164-a5c6-e08a4c9c16f5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2e364433-4723-4bcd-b8a3-c78a38fb60ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a6d91de8-a400-4dd6-b8b8-00e11d62abd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_103fd36f-8744-4164-a5c6-e08a4c9c16f5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a6d91de8-a400-4dd6-b8b8-00e11d62abd7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationScheduleofShareOptionPlansActivityDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#ShareBasedCompensationScheduleofShareOptionPlansActivityDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationScheduleofShareOptionPlansActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationScheduleofRSUsActivityDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#ShareBasedCompensationScheduleofRSUsActivityDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationScheduleofRSUsActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/EmployeeBenefitPlans" xlink:type="simple" xlink:href="jazz-20201231.xsd#EmployeeBenefitPlans"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/EmployeeBenefitPlans" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/EmployeeBenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#EmployeeBenefitPlansNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/EmployeeBenefitPlansNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/IncomeTaxes" xlink:type="simple" xlink:href="jazz-20201231.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="jazz-20201231.xsd#IncomeTaxesTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/IncomeTaxesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/IncomeTaxesComponentsofIncomeBeforeIncomeTaxProvisionBenefitDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#IncomeTaxesComponentsofIncomeBeforeIncomeTaxProvisionBenefitDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/IncomeTaxesComponentsofIncomeBeforeIncomeTaxProvisionBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8b148efc-0630-4f91-a1fa-3f6a53c146d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_0de5547c-0ab3-4999-997d-bf4bc2597cb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8b148efc-0630-4f91-a1fa-3f6a53c146d6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_0de5547c-0ab3-4999-997d-bf4bc2597cb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_a3d6d18d-9979-403e-a0c4-67d278d743b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8b148efc-0630-4f91-a1fa-3f6a53c146d6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_a3d6d18d-9979-403e-a0c4-67d278d743b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeignOther_8338138e-fe7e-441f-8161-4feb281b47b5" xlink:href="jazz-20201231.xsd#jazz_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeignOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8b148efc-0630-4f91-a1fa-3f6a53c146d6" xlink:to="loc_jazz_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeignOther_8338138e-fe7e-441f-8161-4feb281b47b5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/IncomeTaxesDetailsofIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#IncomeTaxesDetailsofIncomeTaxProvisionDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/IncomeTaxesDetailsofIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_79db23f4-5345-4b13-84d5-436c6acd195d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4bcef6b0-a398-46ce-ae8e-5dfe35881c4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_79db23f4-5345-4b13-84d5-436c6acd195d" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4bcef6b0-a398-46ce-ae8e-5dfe35881c4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_65f9d408-ff70-4f54-8afb-770aef435a64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_79db23f4-5345-4b13-84d5-436c6acd195d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_65f9d408-ff70-4f54-8afb-770aef435a64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DeferredIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate_834b3f86-e024-4c68-92f7-1fcdbc6c5c57" xlink:href="jazz-20201231.xsd#jazz_DeferredIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DeferredForeignIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate_eb6dd97b-00f6-4116-bb00-b9117b1dc558" xlink:href="jazz-20201231.xsd#jazz_DeferredForeignIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jazz_DeferredIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate_834b3f86-e024-4c68-92f7-1fcdbc6c5c57" xlink:to="loc_jazz_DeferredForeignIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate_eb6dd97b-00f6-4116-bb00-b9117b1dc558" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DeferredOtherIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate_ef3fcc4b-4d59-44b1-92d4-b6598cc52f2f" xlink:href="jazz-20201231.xsd#jazz_DeferredOtherIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jazz_DeferredIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate_834b3f86-e024-4c68-92f7-1fcdbc6c5c57" xlink:to="loc_jazz_DeferredOtherIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate_ef3fcc4b-4d59-44b1-92d4-b6598cc52f2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a15caee5-d878-4117-968c-02389348f61e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DeferredIncomeTaxExpenseBenefitBeforeEffectOfChangeInTaxRates_a7a6fce3-9b16-4acd-8e08-534786a9efd6" xlink:href="jazz-20201231.xsd#jazz_DeferredIncomeTaxExpenseBenefitBeforeEffectOfChangeInTaxRates"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a15caee5-d878-4117-968c-02389348f61e" xlink:to="loc_jazz_DeferredIncomeTaxExpenseBenefitBeforeEffectOfChangeInTaxRates_a7a6fce3-9b16-4acd-8e08-534786a9efd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DeferredIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate_c4a2a86e-3843-403b-9859-1e6fa170d188" xlink:href="jazz-20201231.xsd#jazz_DeferredIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a15caee5-d878-4117-968c-02389348f61e" xlink:to="loc_jazz_DeferredIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate_c4a2a86e-3843-403b-9859-1e6fa170d188" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6d5d621b-f362-40b7-9c6b-0e0bf0bd3e0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_aedb4902-cb7e-4337-b325-84889540906b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6d5d621b-f362-40b7-9c6b-0e0bf0bd3e0b" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_aedb4902-cb7e-4337-b325-84889540906b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_bfa54835-2014-41e9-a56b-fdf0f8c36e73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6d5d621b-f362-40b7-9c6b-0e0bf0bd3e0b" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_bfa54835-2014-41e9-a56b-fdf0f8c36e73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_5159b6ae-3a23-43b8-8618-9991f5049351" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6d5d621b-f362-40b7-9c6b-0e0bf0bd3e0b" xlink:to="loc_us-gaap_OtherTaxExpenseBenefit_5159b6ae-3a23-43b8-8618-9991f5049351" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DeferredIncomeTaxExpenseBenefitBeforeEffectOfChangeInTaxRates_dd683586-7fe7-4772-80bd-c94c44687dd0" xlink:href="jazz-20201231.xsd#jazz_DeferredIncomeTaxExpenseBenefitBeforeEffectOfChangeInTaxRates"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_95c84e2a-46ee-46ec-9285-813c53acaec2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jazz_DeferredIncomeTaxExpenseBenefitBeforeEffectOfChangeInTaxRates_dd683586-7fe7-4772-80bd-c94c44687dd0" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_95c84e2a-46ee-46ec-9285-813c53acaec2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_3177850e-b0a4-4bc2-ba75-b991757acde4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jazz_DeferredIncomeTaxExpenseBenefitBeforeEffectOfChangeInTaxRates_dd683586-7fe7-4772-80bd-c94c44687dd0" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_3177850e-b0a4-4bc2-ba75-b991757acde4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOtherTaxExpenseBenefit_13c65c1d-d054-40e5-b39c-2d25d60be1a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredOtherTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jazz_DeferredIncomeTaxExpenseBenefitBeforeEffectOfChangeInTaxRates_dd683586-7fe7-4772-80bd-c94c44687dd0" xlink:to="loc_us-gaap_DeferredOtherTaxExpenseBenefit_13c65c1d-d054-40e5-b39c-2d25d60be1a7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_acec9394-ae93-43a1-91bb-ec29ac393feb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_6b3a6044-d20f-4aed-9193-0143fa4ecb88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_acec9394-ae93-43a1-91bb-ec29ac393feb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_6b3a6044-d20f-4aed-9193-0143fa4ecb88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_EffectiveIncomeTaxRateReconciliationIntraEntityTransferOfIntellectualPropertyAssetsPercent_a2679fdb-561f-42c6-a385-6907d7413566" xlink:href="jazz-20201231.xsd#jazz_EffectiveIncomeTaxRateReconciliationIntraEntityTransferOfIntellectualPropertyAssetsPercent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_acec9394-ae93-43a1-91bb-ec29ac393feb" xlink:to="loc_jazz_EffectiveIncomeTaxRateReconciliationIntraEntityTransferOfIntellectualPropertyAssetsPercent_a2679fdb-561f-42c6-a385-6907d7413566" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_757dec7e-4231-4ff1-b15f-88354d3c24ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_acec9394-ae93-43a1-91bb-ec29ac393feb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_757dec7e-4231-4ff1-b15f-88354d3c24ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_ed4dd5e8-f4da-4d85-b5c9-b648c59dcaf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_acec9394-ae93-43a1-91bb-ec29ac393feb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_ed4dd5e8-f4da-4d85-b5c9-b648c59dcaf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_EffectiveIncomeTaxRateReconciliationPatentBoxIncentiveBenefitPercent_6cc2a008-09cc-4e43-9504-a6f1271db9cf" xlink:href="jazz-20201231.xsd#jazz_EffectiveIncomeTaxRateReconciliationPatentBoxIncentiveBenefitPercent"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_acec9394-ae93-43a1-91bb-ec29ac393feb" xlink:to="loc_jazz_EffectiveIncomeTaxRateReconciliationPatentBoxIncentiveBenefitPercent_6cc2a008-09cc-4e43-9504-a6f1271db9cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfConsolidatedSubsidiaryPercent_8e608d48-74af-4afb-bf94-fc05dfb8b920" xlink:href="jazz-20201231.xsd#jazz_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfConsolidatedSubsidiaryPercent"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_acec9394-ae93-43a1-91bb-ec29ac393feb" xlink:to="loc_jazz_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfConsolidatedSubsidiaryPercent_8e608d48-74af-4afb-bf94-fc05dfb8b920" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_76e0e316-fb33-4ed6-87fe-36cba464adb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_acec9394-ae93-43a1-91bb-ec29ac393feb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_76e0e316-fb33-4ed6-87fe-36cba464adb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_64babe67-6b83-45c7-8ed0-419749bce423" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_acec9394-ae93-43a1-91bb-ec29ac393feb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_64babe67-6b83-45c7-8ed0-419749bce423" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_82fdd6e7-84cc-4663-b055-e0afa3c714c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_acec9394-ae93-43a1-91bb-ec29ac393feb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_82fdd6e7-84cc-4663-b055-e0afa3c714c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseFinancingCostsPercent_933466c0-731f-4a9e-ab78-01d41031cce9" xlink:href="jazz-20201231.xsd#jazz_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseFinancingCostsPercent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_acec9394-ae93-43a1-91bb-ec29ac393feb" xlink:to="loc_jazz_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseFinancingCostsPercent_933466c0-731f-4a9e-ab78-01d41031cce9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_01434e1f-a23d-4a82-b8cc-2b3ca9349425" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_acec9394-ae93-43a1-91bb-ec29ac393feb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_01434e1f-a23d-4a82-b8cc-2b3ca9349425" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_EffectiveIncomeTaxRateReconciliationChangeInEstimatePercent_6427a521-bd91-4352-b163-473ceb01a702" xlink:href="jazz-20201231.xsd#jazz_EffectiveIncomeTaxRateReconciliationChangeInEstimatePercent"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_acec9394-ae93-43a1-91bb-ec29ac393feb" xlink:to="loc_jazz_EffectiveIncomeTaxRateReconciliationChangeInEstimatePercent_6427a521-bd91-4352-b163-473ceb01a702" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_b42148db-1c20-4a96-b2b4-08d16e5256c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_acec9394-ae93-43a1-91bb-ec29ac393feb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_b42148db-1c20-4a96-b2b4-08d16e5256c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_be96dd22-53fc-46a4-a087-e3aff5bf1db3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_acec9394-ae93-43a1-91bb-ec29ac393feb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_be96dd22-53fc-46a4-a087-e3aff5bf1db3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_EffectiveIncomeTaxRateReconciliationEstimatedLossContingencyPercent_def34035-0070-4c4a-8a59-0410d1f0d718" xlink:href="jazz-20201231.xsd#jazz_EffectiveIncomeTaxRateReconciliationEstimatedLossContingencyPercent"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_acec9394-ae93-43a1-91bb-ec29ac393feb" xlink:to="loc_jazz_EffectiveIncomeTaxRateReconciliationEstimatedLossContingencyPercent_def34035-0070-4c4a-8a59-0410d1f0d718" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_268f9417-7449-4372-a0a0-cb7a9416d6fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_acec9394-ae93-43a1-91bb-ec29ac393feb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_268f9417-7449-4372-a0a0-cb7a9416d6fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_EffectiveIncomeTaxRateReconciliationDeductionOnSubsidiaryEquityPercent_ac9be642-daba-4330-8170-035af29fdce4" xlink:href="jazz-20201231.xsd#jazz_EffectiveIncomeTaxRateReconciliationDeductionOnSubsidiaryEquityPercent"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_acec9394-ae93-43a1-91bb-ec29ac393feb" xlink:to="loc_jazz_EffectiveIncomeTaxRateReconciliationDeductionOnSubsidiaryEquityPercent_ac9be642-daba-4330-8170-035af29fdce4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_e1a6023c-1044-4449-8352-a714a59b8487" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_acec9394-ae93-43a1-91bb-ec29ac393feb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_e1a6023c-1044-4449-8352-a714a59b8487" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/IncomeTaxesScheduleofNetDeferredTaxAssetsLiabilitiesDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#IncomeTaxesScheduleofNetDeferredTaxAssetsLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/IncomeTaxesScheduleofNetDeferredTaxAssetsLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_05ef1d2e-5e5e-43bc-89f1-8e1a6135fdac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_19634bf8-ddac-4603-add5-08605e2c1a11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_05ef1d2e-5e5e-43bc-89f1-8e1a6135fdac" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_19634bf8-ddac-4603-add5-08605e2c1a11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_ea570532-7c82-4850-84dd-033c42839ed3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_05ef1d2e-5e5e-43bc-89f1-8e1a6135fdac" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_ea570532-7c82-4850-84dd-033c42839ed3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_27f3b08a-27f7-4e41-9dd4-2c03ff3decf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_1155361a-e295-46a5-bb06-e9b896ff6d9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_27f3b08a-27f7-4e41-9dd4-2c03ff3decf4" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_1155361a-e295-46a5-bb06-e9b896ff6d9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_fc7401ea-37d7-4777-8cad-04c0739c7abc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_27f3b08a-27f7-4e41-9dd4-2c03ff3decf4" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_fc7401ea-37d7-4777-8cad-04c0739c7abc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_692434da-771a-4b66-b726-2867d6407ad0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_7b7bfa09-39e5-484c-903f-efe004eceecb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_692434da-771a-4b66-b726-2867d6407ad0" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_7b7bfa09-39e5-484c-903f-efe004eceecb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_da14f2ef-50a3-4a58-bfac-879a344da287" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_692434da-771a-4b66-b726-2867d6407ad0" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_da14f2ef-50a3-4a58-bfac-879a344da287" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_9861be7a-fcc2-4743-bae3-bfc7fdb042b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_7c5d6fa2-dda2-46b9-8067-e57357aa3a6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9861be7a-fcc2-4743-bae3-bfc7fdb042b5" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_7c5d6fa2-dda2-46b9-8067-e57357aa3a6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_e52725cd-1938-4ec7-b79f-19f6272421a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9861be7a-fcc2-4743-bae3-bfc7fdb042b5" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_e52725cd-1938-4ec7-b79f-19f6272421a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_fc87b7de-ab3d-4a22-a974-d3ff2f7691cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9861be7a-fcc2-4743-bae3-bfc7fdb042b5" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_fc87b7de-ab3d-4a22-a974-d3ff2f7691cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4c62b73e-9e3c-49e3-90ad-28a424481d6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9861be7a-fcc2-4743-bae3-bfc7fdb042b5" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4c62b73e-9e3c-49e3-90ad-28a424481d6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_390a245a-acd2-4752-b0fe-390305e48e46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9861be7a-fcc2-4743-bae3-bfc7fdb042b5" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_390a245a-acd2-4752-b0fe-390305e48e46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DeferredTaxAssetsIndirectEffectsOfUnrecognizedTaxBenefits_914d002b-d338-42fb-a0ce-dc057e55ac7c" xlink:href="jazz-20201231.xsd#jazz_DeferredTaxAssetsIndirectEffectsOfUnrecognizedTaxBenefits"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9861be7a-fcc2-4743-bae3-bfc7fdb042b5" xlink:to="loc_jazz_DeferredTaxAssetsIndirectEffectsOfUnrecognizedTaxBenefits_914d002b-d338-42fb-a0ce-dc057e55ac7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DeferredTaxAssetsOperatingLeaseLiability_1c07cfcf-650d-4c09-9f7e-5884bebabe7f" xlink:href="jazz-20201231.xsd#jazz_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9861be7a-fcc2-4743-bae3-bfc7fdb042b5" xlink:to="loc_jazz_DeferredTaxAssetsOperatingLeaseLiability_1c07cfcf-650d-4c09-9f7e-5884bebabe7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_0bec8311-8bee-4bb5-8864-110aeb354d81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9861be7a-fcc2-4743-bae3-bfc7fdb042b5" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_0bec8311-8bee-4bb5-8864-110aeb354d81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_bbc87574-f594-4782-b90f-4753791fa499" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_e7dccf62-f0a8-4e1a-8a67-def813b21ad2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_bbc87574-f594-4782-b90f-4753791fa499" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_e7dccf62-f0a8-4e1a-8a67-def813b21ad2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_2bb3a785-652b-4867-8168-ec77577aad6b" xlink:href="jazz-20201231.xsd#jazz_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_bbc87574-f594-4782-b90f-4753791fa499" xlink:to="loc_jazz_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_2bb3a785-652b-4867-8168-ec77577aad6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_a20e0e46-8de9-48ed-9183-6cdecd4e5621" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_bbc87574-f594-4782-b90f-4753791fa499" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_a20e0e46-8de9-48ed-9183-6cdecd4e5621" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/IncomeTaxesCurrentandNoncurrentDeferredAssetsLiabilitiesDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#IncomeTaxesCurrentandNoncurrentDeferredAssetsLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/IncomeTaxesCurrentandNoncurrentDeferredAssetsLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_fc01ff70-adec-4bd5-b61c-8a76974f5fee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_175393f0-0e92-4446-afe4-008bcbc6f2b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_fc01ff70-adec-4bd5-b61c-8a76974f5fee" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_175393f0-0e92-4446-afe4-008bcbc6f2b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_fe431a94-f414-4775-b9d7-1e9340543a87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_fc01ff70-adec-4bd5-b61c-8a76974f5fee" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_fe431a94-f414-4775-b9d7-1e9340543a87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_1096093f-6dd5-4b16-ae12-f187802b5dba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_1fc56ef7-2cf4-48df-b48b-58bdc48aa195" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_1096093f-6dd5-4b16-ae12-f187802b5dba" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_1fc56ef7-2cf4-48df-b48b-58bdc48aa195" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fd30988f-2ef3-4eee-b90d-4444244c43b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_1096093f-6dd5-4b16-ae12-f187802b5dba" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fd30988f-2ef3-4eee-b90d-4444244c43b2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/SubsequentEvent" xlink:type="simple" xlink:href="jazz-20201231.xsd#SubsequentEvent"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/SubsequentEvent" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/SubsequentEventNarrativeDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#SubsequentEventNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/SubsequentEventNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/QuarterlyFinancialDataUnaudited" xlink:type="simple" xlink:href="jazz-20201231.xsd#QuarterlyFinancialDataUnaudited"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/QuarterlyFinancialDataUnaudited" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/QuarterlyFinancialDataUnauditedTables" xlink:type="simple" xlink:href="jazz-20201231.xsd#QuarterlyFinancialDataUnauditedTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/QuarterlyFinancialDataUnauditedTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/QuarterlyFinancialDataUnauditedScheduleOfInterimFinancialInformationPresentsResultsOfOperationsOnQuarterlyBasisDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#QuarterlyFinancialDataUnauditedScheduleOfInterimFinancialInformationPresentsResultsOfOperationsOnQuarterlyBasisDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/QuarterlyFinancialDataUnauditedScheduleOfInterimFinancialInformationPresentsResultsOfOperationsOnQuarterlyBasisDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ScheduleIIValuationandQualifyingAccounts" xlink:type="simple" xlink:href="jazz-20201231.xsd#ScheduleIIValuationandQualifyingAccounts"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ScheduleIIValuationandQualifyingAccounts" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="jazz-20201231.xsd#ScheduleIIValuationandQualifyingAccountsDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="extended"/>
</link:linkbase>
